Kuala Lumpur General Hospital   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Kuala Lumpur Malaysia (1870)

Organization Overview

First Clinical Trial
2005
NCT00238043
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Department of Nephrology, Kuala Lumpur Hospital | Kuala Lumpur General Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Asthma (Phase 4)

Fatty Liver (Phase 2)

Kidney Diseases (Phase 3)

Kidney Failure, Chronic (Phase 3)

Liver Diseases (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Renal Insufficiency, Chronic (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 15